Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at:

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at:

• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at:

Contact Info:
Name: Shirish Gupta
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL:

For more information, please visit

Source: MarketersMedia

Release ID: 314328

Latest News

Leagues, casinos lobby states for cut of legal sports bets

Mar 20, 2018

WASHINGTON — With the Supreme Court poised to rule on a case that could end the federal ban on sports gambling, more than a third of U.S. states are considering legislation to get in on the action, and professional leagues and casino interests are lobbying against each other for the biggest cut of the winnings. The push to legalize betting on sports has already led to fractures in an uneasy alliance that had developed between leagues and gambling legalization advocates before Supreme Court arguments last fall. The NBA and Major League Baseball have been asking states to give them 1...

Matchups get managed, even in meaningless spring games

Mar 20, 2018

SARASOTA, Fla. — Buck Showalter heard that Lance Lynn was pitching against the Orioles and knew he'd be changing his lineup. The Baltimore manager wasn't concerned about the result of last week's Grapefruit League game against Minnesota, played hours after Lynn officially joined the team. But Showalter figured the right-hander might start when the Twins travel to Camden Yards for a three-game season-opening series later this month. With that in mind, Showalter saw an opportunity. Even in spring training, when wins and losses are meaningless, managers are always hunting for significant matchups. That's especially true along the Florida Gulf Coast,...

Crabbe, LeVert lead Nets over Grizzlies 118-115

Mar 20, 2018

NEW YORK — The Brooklyn Nets proved supreme in another showdown with one of the NBA's worst teams. Allen Crabbe and Caris LeVert each scored 22 points and the Nets beat the Memphis Grizzlies 118-115 on Monday night. Rondae Hollis-Jefferson had 16 points and 12 rebounds, and DeMarre Carroll scored nine of his 18 points in the fourth quarter for the Nets, who have two straight wins for the first time since Jan. 19-21. They won Saturday over Dallas. "He's just a tough winner. It's just who he is," said Nets coach Kenny Atkinson of Carroll's effort. "He's not a...

Griffin's big third quarter helps Pistons top Kings 106-90

Mar 20, 2018

SACRAMENTO, Calif. — After nearly two months, Blake Griffin finally looks comfortable playing with Detroit, and it's showing up across the board. He's even got the Pistons winning on the road again, something that hadn't happened since the five-time All-Star arrived in late January after being traded from the Los Angeles Clippers. Griffin had 26 points, nine rebounds and seven assists, and Detroit pulled away in the third quarter to beat the Sacramento Kings 106-90 on Monday night. "I'm much more settled in now," said Griffin, who has scored 20 or more points in 12 of his 21 games with...

Aldridge's double-double fuels Spurs by Warriors, 89-75

Mar 20, 2018

SAN ANTONIO — LaMarcus Aldridge continued to lead the way for the Spurs, who are trying to find a way to remain in the playoffs. Aldridge had 33 points and 12 rebounds, and San Antonio blew a 16-point lead to the injury-ravaged Golden State Warriors before pulling away for an 89-75 victory on Monday night. "I'm a leader, so I have to do what we need," Aldridge said. "Playing defense, blocking shots, scoring. It all comes with it." San Antonio beat Golden State for the first time in four tries this season and won their fourth straight overall to move...

About Us

The Final Scoreboard has fast, accurate live scores for you. We provide premium online content from in-depth analysis to the scores and statistics across American and European Sports.

Contact us: sales[at]

Subscribe Now!